These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16918401)

  • 1. Emerging peptide therapeutics for inflammatory diseases.
    Vally M; Seenu S; Pillarisetti S
    Curr Pharm Biotechnol; 2006 Aug; 7(4):241-6. PubMed ID: 16918401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
    Yu T; Lao X; Zheng H
    Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.
    Bai R; Yao C; Zhong Z; Ge J; Bai Z; Ye X; Xie T; Xie Y
    Eur J Med Chem; 2021 Mar; 213():113165. PubMed ID: 33454546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.
    Khanapure SP; Garvey DS; Janero DR; Letts LG
    Curr Top Med Chem; 2007; 7(3):311-40. PubMed ID: 17305573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
    Fiorucci S; Distrutti E
    Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Use of Food Protein-Derived Peptides in the Treatment of Inflammatory Diseases.
    Santiago-Lopez L; Gonzalez-Cordova AF; Hernandez-Mendoza A; Vallejo-Cordoba B
    Protein Pept Lett; 2017; 24(2):137-145. PubMed ID: 28017144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade.
    Sala A; Proschak E; Steinhilber D; Rovati GE
    Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review].
    Mateos JL
    Drugs Today (Barc); 2010 Feb; 46 Suppl A():1-25. PubMed ID: 20224826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
    Biava M; Porretta GC; Poce G; Battilocchio C; Botta M; Manetti F; Rovini M; Cappelli A; Sautebin L; Rossi A; Pergola C; Ghelardini C; Galeotti N; Makovec F; Giordani A; Anzellotti P; Tacconelli S; Patrignani P; Anzini M
    Curr Med Chem; 2011; 18(10):1540-54. PubMed ID: 21428878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation.
    Wallace JL
    ScientificWorldJournal; 2006 May; 6():577-88. PubMed ID: 16752007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and anti-arthritic effects of new synthetic 3-(4-hydroxyphenyl)-4-(4-thiomethoxyphenyl)-1H-pyrrole-2,5-dione.
    Shin JS; Noh YS; Yoo MS; Lee JY; Cho YW; Lee KT
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2221-5. PubMed ID: 22349257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target.
    Gejjalagere Honnappa C; Mazhuvancherry Kesavan U
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):562-571. PubMed ID: 27707958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products.
    Wang RX; Zhou M; Ma HL; Qiao YB; Li QS
    ChemMedChem; 2021 May; 16(10):1576-1592. PubMed ID: 33528076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
    Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
    Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for the treatment of rheumatoid arthritis.
    Schuna AA; Megeff C
    Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
    Nurmohamed MT; van Halm VP; Dijkmans BA
    Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.